Document Detail


The double-blind, randomized, placebo-controlled trial: gold standard or golden calf?
MedLine Citation:
PMID:  11377113     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The double-blind randomized controlled trial (RCT) is accepted by medicine as objective scientific methodology that, when ideally performed, produces knowledge untainted by bias. The validity of the RCT rests not just on theoretical arguments, but also on the discrepancy between the RCT and less rigorous evidence (the difference is sometimes considered an objective measure of bias). A brief overview of historical and recent developments in "the discrepancy argument" is presented. The article then examines the possibility that some of this "deviation from truth" may be the result of artifacts introduced by the masked RCT itself. Can an "unbiased" method produce bias? Among the experiments examined are those that augment the methodological stringency of a normal RCT in order to render the experiment less susceptible to subversion by the mind. This methodology, a hypothetical "platinum" standard, can be used to judge the "gold" standard. The concealment in a placebo-controlled RCT seems capable of generating a "masking bias." Other potential biases, such as "investigator self-selection," "preference," and "consent" are also briefly discussed. Such potential distortions indicate that the double-blind RCT may not be objective in the realist sense, but rather is objective in a "softer" disciplinary sense. Some "facts" may not exist independent of the apparatus of their production.
Authors:
T J Kaptchuk
Related Documents :
15985873 - Executive control function in psychiatric and medical illness.
2662163 - The worst headache ever. 1. ominous causes.
17224433 - An isokinetic eccentric programme for the management of chronic lateral epicondylar ten...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical epidemiology     Volume:  54     ISSN:  0895-4356     ISO Abbreviation:  J Clin Epidemiol     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-05-29     Completed Date:  2001-06-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8801383     Medline TA:  J Clin Epidemiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  541-9     Citation Subset:  IM    
Affiliation:
Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, KW-400, Boston, MA 02215, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bias (Epidemiology)
Double-Blind Method
Humans
Informed Consent
Outcome Assessment (Health Care)
Placebos
Randomized Controlled Trials as Topic* / standards
Chemical
Reg. No./Substance:
0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebral blood flow velocity in two patients with neonatal cerebral infarction.
Next Document:  The randomized placebo-phase design for clinical trials.